Abstract
Where memory is stored and how it is processed is poorly understood. Traditionally, genetics of low prevalence traits have been used to get a better understanding of naturally occuring conditions across species. Here, we conduct a genome-wide association of transient global amnesia (TGA), a specific type of heritable amnesia characterized by a sudden, temporary episode of memory loss, across 4,303 patients and over 1 million controls from three population biobanks in Finland, United States, and the United Kingdom, to better understand the genetic basis of memory. We find nine loci associated with TGA (p < 5×10-8) including a missense variant in CRIP1 with high posterior probability (> .9) of being the causally relevant variant using fine-mapping, replicated across 3 cohorts. Furthermore, we find enrichment for a specific cell type, pericyte cells, which are a key part of the neurovascular unit, which includes astrocytes and neurons, and control interactions between neurons and the cerebral vasculature, implicating a direct vascular role in memory formation and retrieval. We anticipate these genetic studies at a larger scale to bring new biological understanding and therapeutic insights into the brain and memory.
Competing Interest Statement
MAR is a co-Founder of Broadwing Bio. MJD is a co-Founder of Maze Therapeutics.
Funding Statement
Funding was made available by Stanford University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail: mrivas{at}stanford.edu and mjdaly{at}broadinstitute.org
Data Availability
Summary statistic data are available from the AllofUS workbench, UK Biobank RAP, and FinnGen browser.
